Leucovorin



Indications and Reactions:

Role Indications Reactions
Primary
Colon Cancer 31.3%
Drug Use For Unknown Indication 12.5%
Colorectal Cancer Metastatic 7.8%
Pancreatic Carcinoma 7.8%
Biliary Neoplasm 6.3%
Duodenal Carcinoma Recurrent 6.3%
Eye Infection Toxoplasmal 6.3%
Colon Cancer Metastatic 4.7%
Small Intestine Carcinoma 4.7%
Colorectal Cancer 3.1%
Metastatic Colorectal Cancer 3.1%
Acute Lymphocytic Leukaemia 1.6%
Esophageal Cancer 1.6%
Neoplasm Malignant 1.6%
Neurological Symptom 1.6%
Sudden Death 9.1%
Vomiting 9.1%
Cerebrovascular Accident 4.5%
Febrile Neutropenia 4.5%
Hepatic Necrosis 4.5%
Hypersensitivity 4.5%
Malaise 4.5%
Metastases To Liver 4.5%
Neuropathy Peripheral 4.5%
Neurotoxicity 4.5%
Osteonecrosis 4.5%
Pain 4.5%
Pleural Effusion 4.5%
Pneumonia 4.5%
Pulmonary Embolism 4.5%
Pulmonary Oedema 4.5%
Pulmonary Thrombosis 4.5%
Rash 4.5%
Recurrent Cancer 4.5%
Respiratory Failure 4.5%
Secondary
Colorectal Cancer Metastatic 32.0%
Colorectal Cancer 11.3%
Colon Cancer 9.3%
Acute Lymphocytic Leukaemia 8.8%
Drug Use For Unknown Indication 5.2%
Product Used For Unknown Indication 4.3%
Gastric Cancer 3.4%
Rectal Cancer 3.3%
Prophylaxis 3.2%
Chromosome Analysis Abnormal 2.9%
Colon Cancer Metastatic 2.8%
Oesophageal Cancer Metastatic 2.3%
Metastases To Liver 2.0%
Hypertension 2.0%
Pancreatic Carcinoma 1.7%
B-cell Lymphoma 1.5%
Lymphocytic Leukaemia 1.2%
Adenocarcinoma Gastric 0.9%
Adenocarcinoma 0.9%
Premedication 0.9%
Vomiting 20.5%
Sepsis 7.4%
Diarrhoea 7.1%
Neutropenia 7.1%
Thrombocytopenia 6.2%
Pyrexia 5.5%
Respiratory Failure 5.5%
Febrile Neutropenia 4.6%
Toxicity To Various Agents 4.6%
Death 4.1%
Stomatitis 3.4%
White Blood Cell Count Decreased 3.4%
Disease Progression 3.0%
Infection 3.0%
Hypertension 2.8%
Pulmonary Embolism 2.8%
Dyspnoea 2.5%
Sudden Death 2.3%
General Physical Health Deterioration 2.1%
Syncope 2.1%
Concomitant
Product Used For Unknown Indication 18.6%
Acute Lymphocytic Leukaemia 12.6%
Prophylaxis 12.5%
Rheumatoid Arthritis 10.0%
Colon Cancer 7.9%
Colorectal Cancer 6.2%
Colorectal Cancer Metastatic 5.6%
Colon Cancer Metastatic 4.1%
Chromosome Analysis Abnormal 2.9%
Drug Use For Unknown Indication 2.6%
Chemotherapy 2.1%
Pain 1.9%
Premedication 1.9%
Rectal Cancer Metastatic 1.8%
Nausea 1.8%
Neoplasm Malignant 1.8%
Rectal Cancer 1.7%
Hypertension 1.5%
Gastric Cancer 1.3%
B-cell Lymphoma 1.3%
Death 15.2%
Disease Progression 15.2%
Vomiting 13.9%
Toxicity To Various Agents 5.6%
Thrombocytopenia 5.0%
Urinary Tract Infection 4.0%
Weight Decreased 4.0%
Neutropenia 3.6%
Rash 3.6%
White Blood Cell Count Decreased 3.6%
Pyrexia 3.3%
Sepsis 3.3%
Leukoencephalopathy 2.6%
Off Label Use 2.6%
Renal Failure Acute 2.6%
Throat Irritation 2.6%
Neuropathy Peripheral 2.3%
Pulmonary Embolism 2.3%
Thrombotic Thrombocytopenic Purpura 2.3%
Pancytopenia 2.0%